Baidu (NASDAQ:BIDU – Get Free Report) had its target price reduced by analysts at Nomura from $196.00 to $186.00 in a report issued on Friday,MarketScreener reports. The brokerage currently has a “buy” rating on the information services provider’s stock. Nomura’s price objective points to a potential upside of 56.58% from the stock’s previous close. BIDU […]

uniQure (NASDAQ:QURE – Free Report) had its target price cut by Chardan Capital from $53.00 to $16.00 in a report released on Tuesday,Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. A number of other brokerages also recently commented on QURE. Weiss Ratings restated a “sell (d-)” rating on shares of […]

Tevogen Bio (NASDAQ:TVGN – Free Report) had its price objective reduced by D. Boral Capital from $5.00 to $2.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have a buy rating on the stock. Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Tevogen Bio in a report on […]